DrugPatentWatch Database Preview

Litigation Details for VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)

Docket		Date Filed	2015-04-15
Court	District Court, D. New Jersey	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Stanley R. Chesler
Jury Demand	None	Referred To	Cathy L. Waldor
Parties	TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.; VIVUS, INC.
Patents	7,056,890; 7,553,818; 7,659,256; 7,674,776; 8,580,298; 8,580,299; 8,895,057; 8,895,058; 9,011,905; 9,011,906
Attorneys	CHARLES MICHAEL LIZZA; MAYRA VELEZ TARANTINO; MICHAEL E. PATUNAS; SARAH ANN SULLIVAN; WILLIAM C. BATON
Link to Docket	External link to docket

Details for VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-06-18	14		.S. Patent No. 7,056,890; (b) declaring that the claims of U.S. Patent No. 7,056,890 are … United States Patent Nos. 7,056,890 (the “’890 patent”), 7,553,818 (the “’818 patent”), 7,659,256 (the…United States Patent Nos. 7,056,890 (the “’890 patent”), 7,553,818 (the “’818 patent”), 7,659,256 (the…890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 patent, the…890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 patent, the	External link to document
2016-07-20	60		claims in U.S Patent Nos. 7,056,890 (“the ’890 patent”), 7,553,818 (“the ’818 patent”), 7,659,256 (“…the ’299 patent, the ’057 patent, the ’058 patent, the ’905 patent, and the ’096 patent. Defendants …the ’890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299…299 patent, the ’057 patent, the ’058 patent, the ’905 patent, and the ’906 patent. 2. “topiramate…the ’890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299	External link to document